嗜睡症治療藥的全球市場:2022年～2026年

全球嗜睡症治療藥的市場規模在2022年～2026年間，預測將成長到16億美元，在預測期間內預計將以9.1％的年複合成長率增長。

市場成長的主要因素有產品發布和臨床試驗增加、成人發作性睡病病例增加以及對發作性睡病原因和治療的研究增加等。

本報告涵括嗜睡症治療藥的全球市場的整體分析，提供市場規模與預測，趨勢，成長促進因素，課題，及約25供應商的分析。

目錄

第1章 摘要整理

• 市場概要

第2章 市場形勢

• 市場生態系統

第3章 市場規模

• 市場定義
• 市場區隔分析
• 2021年的市場規模
• 市場預測:從2021年～2026年的預測

第4章 波特的五力分析

• 五力彙整
• 買方議價能力
• 供給企業談判力
• 新加入廠商業者的威脅
• 替代品的威脅
• 競爭的威脅
• 市場情況

第5章 市場區隔:各類型

• 市場區隔
• 各類型的比較
• 發作性睡病伴猝倒:市場規模與預測(2021年～2026年)
• 無猝倒的嗜睡症:市場規模與預測(2021年～2026年)
• 次發性嗜睡症:市場規模與預測(2021年～2026年)
• 各類型的市場機會

第6章 客戶形勢

• 客戶形勢概要

第7章 各地區形勢

• 各地區市場區隔
• 各地區的比較
• 北美:市場規模與預測(2021年～2026年)
• 歐洲:市場規模與預測(2021年～2026年)
• 亞洲:市場規模與預測(2021年～2026年)
• 其他地區:市場規模與預測(2021年～2026年)
• 美國:市場規模與預測(2021年～2026年)
• 德國:市場規模與預測(2021年～2026年)
• 英國:市場規模與預測(2021年～2026年)
• 加拿大:市場規模與預測(2021年～2026年)
• 法國:市場規模與預測(2021年～2026年)
• 各地區形勢的市場機會

第8章 推動要素，課題，及趨勢

• 市場推動要素
• 市場課題
• 推動要素與課題的影響
• 市場趨勢

第9章 業者情勢

• 概要
• 業者情勢
• 混亂狀況
• 產業的風險

第10章 供應商分析

• 交易廠商
• 供應商的市場定位
• Alkermes Public Ltd. Co.
• Avadel Pharmaceuticals plc
• Axsome Therapeutics Inc.
• BIOPROJET
• Jazz Pharmaceuticals Plc
• Shionogi and Co. Ltd.
• Somacare
• Takeda Pharmaceutical Co. Ltd.
• Teva Pharmaceutical Industries Ltd.
• XWPharma Ltd.

第11章 附錄

Technavio has been monitoring the narcolepsy drugs market and is poised to grow by $ 1.60 bn during 2022-2026, accelerating at a CAGR of 9.1% during the forecast period. Our report on the narcolepsy drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising product launches and clinical trials, rising cases of narcolepsy in adults, and a rising number of studies to understand the cause and treatment of narcolepsy.

The narcolepsy drugs market analysis includes the type segment and geographic landscape.

Technavio's narcolepsy drugs market is segmented as below:

By Type

• Narcolepsy with cataplexy
• Narcolepsy without cataplexy
• Secondary narcolepsy

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the advancement in narcolepsy treatment as one of the prime reasons driving the narcolepsy drugs market growth during the next few years. Also, increasing demand for non-pharmacological therapies and combination treatments for narcolepsy will lead to sizable demand in the market.

• Narcolepsy drugs market sizing
• Narcolepsy drugs market forecast
• Narcolepsy drugs market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading narcolepsy drugs market vendors that include Alkermes Public Ltd. Co., Apotex Inc., Aurobindo Pharma Ltd., Avadel Pharmaceuticals plc, Axsome Therapeutics Inc., BIOPROJET, Cadila Pharmaceuticals Ltd., Don Valley Pharma, Graymark Healthcare Inc., Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals Plc, Luckys Pharma Pvt. Ltd., Midas Pharma GmbH, Orbion Pharmaceuticals Pvt. Ltd., Shionogi and Co. Ltd., Somacare, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and XWPharma Ltd. Also, the narcolepsy drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all future growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Table of Contents

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary - Chart on Market Overview
• Exhibit 02: Executive Summary - Data Table on Market Overview
• Exhibit 03: Executive Summary - Chart on Global Market Characteristics
• Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
• Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
• Exhibit 06: Executive Summary - Chart on Incremental Growth
• Exhibit 07: Executive Summary - Data Table on Incremental Growth
• Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition
• 3.2 Market segment analysis
• Exhibit 12: Market segments
• 3.3 Market size 2021
• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

• 5.1 Market segments
• Exhibit 24: Chart on Type - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
• 5.2 Comparison by Type
• Exhibit 26: Chart on Comparison by Type
• Exhibit 27: Data Table on Comparison by Type
• 5.3 Narcolepsy with cataplexy - Market size and forecast 2021-2026
• Exhibit 28: Chart on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
• 5.4 Narcolepsy without cataplexy - Market size and forecast 2021-2026
• Exhibit 32: Chart on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
• 5.5 Secondary narcolepsy - Market size and forecast 2021-2026
• Exhibit 36: Chart on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
• 5.6 Market opportunity by Type
• Exhibit 40: Market opportunity by Type ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• 7.2 Geographic comparison
• Exhibit 44: Chart on Geographic comparison
• Exhibit 45: Data Table on Geographic comparison
• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• 7.7 US - Market size and forecast 2021-2026
• Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
• 7.8 Germany - Market size and forecast 2021-2026
• Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• 7.9 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• 7.10 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• 7.11 France - Market size and forecast 2021-2026
• Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
• 7.12 Market opportunity By Geographical Landscape
• Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers
• 8.2 Market challenges
• 8.3 Impact of drivers and challenges
• Exhibit 83: Impact of drivers and challenges in 2021 and 2026
• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview
• 9.2 Vendor landscape
• Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
• 9.3 Landscape disruption
• Exhibit 85: Overview on factors of disruption
• 9.4 Industry risks
• Exhibit 86: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 87: Vendors covered
• 10.2 Market positioning of vendors
• Exhibit 88: Matrix on vendor position and classification
• 10.3 Alkermes Public Ltd. Co.
• Exhibit 89: Alkermes Public Ltd. Co. - Overview
• Exhibit 90: Alkermes Public Ltd. Co. - Product / Service
• Exhibit 91: Alkermes Public Ltd. Co. - Key news
• Exhibit 92: Alkermes Public Ltd. Co. - Key offerings
• 10.4 Avadel Pharmaceuticals plc
• Exhibit 93: Avadel Pharmaceuticals plc - Overview
• Exhibit 94: Avadel Pharmaceuticals plc - Business segments
• Exhibit 95: Avadel Pharmaceuticals plc - Key news
• Exhibit 96: Avadel Pharmaceuticals plc - Key offerings
• Exhibit 97: Avadel Pharmaceuticals plc - Segment focus
• 10.5 Axsome Therapeutics Inc.
• Exhibit 98: Axsome Therapeutics Inc. - Overview
• Exhibit 99: Axsome Therapeutics Inc. - Product / Service
• Exhibit 100: Axsome Therapeutics Inc. - Key offerings
• 10.6 BIOPROJET
• Exhibit 101: BIOPROJET - Overview
• Exhibit 102: BIOPROJET - Product / Service
• Exhibit 103: BIOPROJET - Key offerings
• 10.7 Jazz Pharmaceuticals Plc
• Exhibit 104: Jazz Pharmaceuticals Plc - Overview
• Exhibit 105: Jazz Pharmaceuticals Plc - Product / Service
• Exhibit 106: Jazz Pharmaceuticals Plc - Key news
• Exhibit 107: Jazz Pharmaceuticals Plc - Key offerings
• 10.8 Shionogi and Co. Ltd.
• Exhibit 108: Shionogi and Co. Ltd. - Overview
• Exhibit 109: Shionogi and Co. Ltd. - Product / Service
• Exhibit 110: Shionogi and Co. Ltd. - Key offerings
• 10.9 Somacare
• Exhibit 111: Somacare - Overview
• Exhibit 112: Somacare - Product / Service
• Exhibit 113: Somacare - Key offerings
• 10.10 Takeda Pharmaceutical Co. Ltd.
• Exhibit 114: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibit 115: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibit 116: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibit 117: Takeda Pharmaceutical Co. Ltd. - Key offerings
• 10.11 Teva Pharmaceutical Industries Ltd.
• Exhibit 118: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibit 119: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibit 120: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibit 121: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibit 122: Teva Pharmaceutical Industries Ltd. - Segment focus
• 10.12 XWPharma Ltd.
• Exhibit 123: XWPharma Ltd. - Overview
• Exhibit 124: XWPharma Ltd. - Product / Service
• Exhibit 125: XWPharma Ltd. - Key offerings

11 Appendix

• 11.1 Scope of the report
• 11.2 Inclusions and exclusions checklist
• Exhibit 126: Inclusions checklist
• Exhibit 127: Exclusions checklist
• 11.3 Currency conversion rates for US$
• Exhibit 128: Currency conversion rates for US$
• 11.4 Research methodology
• Exhibit 129: Research methodology
• Exhibit 130: Validation techniques employed for market sizing
• Exhibit 131: Information sources
• 11.5 List of abbreviations
• Exhibit 132: List of abbreviations

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Type
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Vendor Market Positioning
• Exhibits9: Parent market
• Exhibits10: Market Characteristics
• Exhibits11: Offerings of vendors included in the market definition
• Exhibits12: Market segments
• Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibits17: Five forces analysis - Comparison between 2021 and 2026
• Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
• Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
• Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
• Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
• Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
• Exhibits23: Chart on Market condition - Five forces 2021 and 2026
• Exhibits24: Chart on Type - Market share 2021-2026 (%)
• Exhibits25: Data Table on Type - Market share 2021-2026 (%)
• Exhibits26: Chart on Comparison by Type
• Exhibits27: Data Table on Comparison by Type
• Exhibits28: Chart on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibits29: Data Table on Narcolepsy with cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibits30: Chart on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibits31: Data Table on Narcolepsy with cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibits32: Chart on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibits33: Data Table on Narcolepsy without cataplexy - Market size and forecast 2021-2026 ($ million)
• Exhibits34: Chart on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibits35: Data Table on Narcolepsy without cataplexy - Year-over-year growth 2021-2026 (%)
• Exhibits36: Chart on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
• Exhibits37: Data Table on Secondary narcolepsy - Market size and forecast 2021-2026 ($ million)
• Exhibits38: Chart on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
• Exhibits39: Data Table on Secondary narcolepsy - Year-over-year growth 2021-2026 (%)
• Exhibits40: Market opportunity by Type ($ million)
• Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
• Exhibits44: Chart on Geographic comparison
• Exhibits45: Data Table on Geographic comparison
• Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
• Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
• Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
• Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
• Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
• Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
• Exhibits74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibits76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits77: Data Table on Canada - Year-over-year growth 2021-2026 (%)
• Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
• Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
• Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
• Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
• Exhibits82: Market opportunity By Geographical Landscape ($ million)
• Exhibits83: Impact of drivers and challenges in 2021 and 2026
• Exhibits84: Overview on Criticality of inputs and Factors of differentiation
• Exhibits85: Overview on factors of disruption
• Exhibits86: Impact of key risks on business
• Exhibits87: Vendors covered
• Exhibits88: Matrix on vendor position and classification
• Exhibits89: Alkermes Public Ltd. Co. - Overview
• Exhibits90: Alkermes Public Ltd. Co. - Product / Service
• Exhibits91: Alkermes Public Ltd. Co. - Key news
• Exhibits92: Alkermes Public Ltd. Co. - Key offerings
• Exhibits93: Avadel Pharmaceuticals plc - Overview
• Exhibits94: Avadel Pharmaceuticals plc - Business segments
• Exhibits95: Avadel Pharmaceuticals plc - Key news
• Exhibits96: Avadel Pharmaceuticals plc - Key offerings
• Exhibits97: Avadel Pharmaceuticals plc - Segment focus
• Exhibits98: Axsome Therapeutics Inc. - Overview
• Exhibits99: Axsome Therapeutics Inc. - Product / Service
• Exhibits100: Axsome Therapeutics Inc. - Key offerings
• Exhibits101: BIOPROJET - Overview
• Exhibits102: BIOPROJET - Product / Service
• Exhibits103: BIOPROJET - Key offerings
• Exhibits104: Jazz Pharmaceuticals Plc - Overview
• Exhibits105: Jazz Pharmaceuticals Plc - Product / Service
• Exhibits106: Jazz Pharmaceuticals Plc - Key news
• Exhibits107: Jazz Pharmaceuticals Plc - Key offerings
• Exhibits108: Shionogi and Co. Ltd. - Overview
• Exhibits109: Shionogi and Co. Ltd. - Product / Service
• Exhibits110: Shionogi and Co. Ltd. - Key offerings
• Exhibits111: Somacare - Overview
• Exhibits112: Somacare - Product / Service
• Exhibits113: Somacare - Key offerings
• Exhibits114: Takeda Pharmaceutical Co. Ltd. - Overview
• Exhibits115: Takeda Pharmaceutical Co. Ltd. - Product / Service
• Exhibits116: Takeda Pharmaceutical Co. Ltd. - Key news
• Exhibits117: Takeda Pharmaceutical Co. Ltd. - Key offerings
• Exhibits118: Teva Pharmaceutical Industries Ltd. - Overview
• Exhibits119: Teva Pharmaceutical Industries Ltd. - Business segments
• Exhibits120: Teva Pharmaceutical Industries Ltd. - Key news
• Exhibits121: Teva Pharmaceutical Industries Ltd. - Key offerings
• Exhibits122: Teva Pharmaceutical Industries Ltd. - Segment focus
• Exhibits123: XWPharma Ltd. - Overview
• Exhibits124: XWPharma Ltd. - Product / Service
• Exhibits125: XWPharma Ltd. - Key offerings
• Exhibits126: Inclusions checklist
• Exhibits127: Exclusions checklist
• Exhibits128: Currency conversion rates for US$
• Exhibits129: Research methodology
• Exhibits130: Validation techniques employed for market sizing
• Exhibits131: Information sources
• Exhibits132: List of abbreviations